Introduction {#S1}
============

Infectious proteins, or prions, are a form of conformation-based inheritance, in which a prion protein aggregate binds to and catalyzes the conversion of newly-made proteins to the prion form creating stably propagating states[@R1]. Such conformation-based inheritance underlies a range of transmissible spongiform encephalopathies in mammals as well as heritable epigenetic states in fungi, of which the yeast *Saccharomyces cerevisiae* prion \[*PSI^+^*\] is arguably the best characterized[@R2]. A common feature of prion proteins is that they misfold into ordered, β-sheet rich amyloid fibers, the self-templating nature of which is thought to form the basis of prion propagation[@R1],[@R3]. Remarkably, a single prion protein can adopt a spectrum of amyloid conformations that lead to different, heritable strain variants[@R4]--[@R11].

The yeast prion \[*PSI^+^*\], which results from the aggregation of the translation termination factor Sup35p, has emerged as a powerful system for studying strain variants. Sup35p can form different amyloid conformations *in vitro* when polymerized at 4 °C versus 37 °C[@R8],[@R12],[@R13]. When introduced into yeast, these amyloid fibers form two distinct strains *in vivo* termed \[*PSI^+^*\]^Sc4^ and \[*PSI^+^*\]^Sc37^, respectively. (For clarity, we use \[*PSI^+^*\]^Sc4^ to describe the *in vivo* strain and Sc4 to describe the fiber conformation.) These strains are distinguished by the degree of Sup35p aggregation: \[*PSI^+^*\]^Sc4^ yeast exhibit a strong prion phenotype, in which the large majority of Sup35p is aggregated, while \[*PSI^+^*\]^Sc37^ yeast have a more substantial pool of soluble Sup35p and a weaker prion phenotype. Structural studies revealed that there is a dramatic expansion of the amyloid core in the Sc37 conformation relative to that found in Sc4[@R14],[@R15]. The more extensive structure in Sc37 fibers increases fiber stability and decreases the rate of prion replication by the cell's chaperone system resulting in the weaker \[*PSI^+^*\]^Sc37^ prion phenotype[@R16]. The ability to probe the biophysical properties of these defined strain variant conformations *in vitro* and monitor their phenotypes *in vivo* makes \[*PSI^+^*\] an excellent system for the study of prion strain phenomena.

The precise amino acid sequence greatly biases the ability of a prion protein to adopt particular strain variants[@R7],[@R17]--[@R19]. For example, the naturally occurring methionine/valine polymorphism at position 129 of the mammalian prion protein greatly influences disease susceptibility[@R20]. The Val^129^ allele does not interfere with the propagation of all prion strain variants and may even favor some, including certain iatrogenic forms of Creutzfeldt-Jakob diease[@R19]. However, the presence of even a single allele of Val^129^ appears to be highly protective against developing new variant Creutzfeldt-Jakob disease (nvCJD)[@R21], which is thought to result from transmission of bovine spongiform encephalopathy (mad cow disease) to humans[@R22],[@R23].

This strong relationship between strain variants and the sequence of the prion protein extends to the \[*PSI^+^*\] prion system. A mutant of the Sup35p prion protein, which was originally identified in a screen for "Psi no more" mutants that prevented propagation of \[*PSI^+^*\], shows strain variant-specific effects. This mutant, termed PNM2, has a glycine to aspartate missense mutation at amino acid position 58[@R24]. Originally, the effect of PNM2 was described as causing dominant inhibition of prion propagation when co-expressed with wild type Sup35p[@R24],[@R25]. Later studies found that PNM2 does not interfere with propagation of all \[*PSI^+^*\] strain variants and may enhance propagation of certain strain variants when overexpressed[@R17].

Here, we used the PNM2 mutant and the well-defined prion strain conformations, Sc4 and Sc37, together with in-depth biophysical and *in vivo* analyses, to investigate how point mutations can affect prion propagation in a manner that depends on the strain variant. Our systematic characterization of fiber structure, chaperone-mediated division of fibers into seeds and delivery of seeds to daughter cells reveals a PNM2-specific defect in seed partitioning for the \[*PSI^+^*\]^Sc4^ strain variant. The findings implicate delivery of fiber seeds to daughter buds as a critical step in prion propagation.

Results {#S2}
=======

PNM2 shows strain-specific effects on \[*PSI^+^*\] propagation {#S3}
--------------------------------------------------------------

We began by characterizing the effect of the PNM2 mutation on prion propagation in \[*PSI^+^*\]^Sc4^ and \[*PSI^+^*\]^Sc37^ yeast. To allow for rapid exchange of alleles, we used a yeast background in which the genomic copy of *SUP35* was deleted and replaced by a copy on a plasmid containing the counter-selectable *URA3* marker. We exchanged this plasmid with one encoding wild-type Sup35p (WT) or Sup35p G58D (PNM2) and confirmed that the two proteins were expressed at similar levels ([Fig. 1a](#F1){ref-type="fig"}). We assessed the prion phenotype with a red/white color readout that results from suppression of a nonsense mutation in an *ADE1* reporter (the *ade1--14* allele)[@R26]. When Sup35p is soluble (\[*psi*^−^\]), translation of *ade1--14* terminates prematurely, resulting in accumulation of a red metabolic intermediate. When Sup35p is aggregated (\[*PSI^+^*\]), read-through of the nonsense mutation occurs and functional Ade1p is produced. Depending on the amount of soluble Sup35p present and perhaps the nature of the aggregates, \[*PSI*^+^\] strain variants have varying levels of functional Ade1p and exhibit color phenotypes ranging from pink (\[*PSI^+^*\]^Sc37^) to white (\[*PSI^+^*\]^Sc4^) ([Fig. 1b](#F1){ref-type="fig"}). This assay also reports on the stability of prion inheritance: when a cell in a growing colony loses \[*PSI^+^*\], its progeny remain prion free and form a red sector ([Fig. 1c](#F1){ref-type="fig"}).

Using the \[*PSI^+^*\]^Sc4^ and \[*PSI^+^*\]^Sc37^ yeast backgrounds, we found that PNM2 has dramatic, strain variant-specific effects on prion propagation. When expressed as the sole copy of Sup35p, PNM2 strongly compromised propagation of \[*PSI^+^*\]^Sc4^, apparent by the continuous generation of prion-free (\[*psi*^−^\]) states ([Fig. 1b,c,d](#F1){ref-type="fig"}). This effect is similar to the originally reported description of the PNM2 phenotype[@R24],[@R25], though there are differences between studies: PNM2 is recessive in our strain background and thus does not strongly interfere with \[*PSI^+^*\]^Sc4^ propagation when co-expressed with WT ([Fig. 1b](#F1){ref-type="fig"}). Thus, we focused on analyzing effects of prion propagation when PNM2 is expressed as the sole copy of Sup35p.

In contrast to its dramatic effect on \[*PSI^+^*\]^Sc4^ propagation, PNM2 had a much weaker effect on propagation of the \[*PSI^+^*\]^Sc37^ strain variant, with at most a mild darkening of the color phenotype and no discernable increase in prion loss ([Fig. 1b,d](#F1){ref-type="fig"}). This result was surprising given that previous studies indicate that the PNM2 mutation is located in a region that is structured in Sc37 but not in Sc4[@R15], leading to the expectation that the PNM2 mutation would preferentially interfere with propagation of the Sc37 conformation.

We first asked whether the defect in stable inheritance seen in \[*PSI^+^*\]^Sc4^ yeast could arise from the PNM2 mutation forcing an irreversible structural change that results in an amyloid conformation that is poorly propagated. We carried out a series of plasmid exchanges, replacing the WT plasmid with the PNM2 plasmid, then exchanging it back with the WT plasmid. Reintroduction of the WT plasmid fully restored the original \[*PSI*^+^\]^Sc4^ phenotype ([Fig. 1e](#F1){ref-type="fig"}), indicating that the PNM2 Sc4 fibers retained the structural information necessary to template WT to the characteristic Sc4 amyloid conformation.

To investigate what accounts for the negative impact of PNM2 on \[*PSI^+^*\]^Sc4^, but not on \[*PSI^+^*\]^Sc37^, propagation, we systematically tested the parameters that affect each step in the prion replication cycle ([Fig. 2](#F2){ref-type="fig"}): fiber growth; fiber division, of which fiber stability and ability to interact with the *in vivo* chaperone prion-replication machinery are key determinants; and delivery of prion particles to daughter cells during cell division.

PNM2 disrupts Sc37 growth rate and structural stability {#S4}
-------------------------------------------------------

To determine whether changes in fiber growth rates account for the observed phenotypic differences, we compared *in vitro* growth rates of WT and PNM2 fibers. While earlier studies found that PNM2 fibers have a partial growth defect, the nature of the prion strain variants in these studies was not well defined[@R27]. For our studies, we used a fragment of Sup35p (SupNM; residues 1--254, containing the Q/N-rich N-terminal and highly charged middle domains of Sup35p) that is necessary and sufficient to support prion propagation[@R28],[@R29]. The seeded polymerization rates of soluble SupNM were monitored by measuring the increase in fluorescence intensity of Thioflavin T. We found that when seeded, PNM2 SupNM polymerizes into the Sc37 conformation at a rate slower than that observed with WT SupNM ([Fig. 3](#F3){ref-type="fig"}). Since this change in growth rate would be predicted to weaken the prion phenotype, other mechanisms must account for the similar phenotype of PNM2 and WT in the Sc37 conformation.

A PNM2-induced change in amyloid structure could explain the change in Sc37 fiber growth rate as well as provide insight into prion division rates *in vivo*[@R16]. Therefore, we used a range of biophysical techniques, including hydrogen/deuterium (H/D) exchange NMR, fiber thermal denaturation, and propensity for shearing to produce new fiber seeds, to analyze the structure and stability of PNM2 SupNM fibers. Shearing efficacy was determined by the ability of long fibers fragmented via stirring to seed monomer growth as measured from the initial polymerization rates of such reactions.

For the H/D exchange experiments, we monitored the extent of backbone amide exchange for both WT and PNM2 fibers at two different time points: after a short exchange period of 2 minutes and after a more extensive exchange period of 1 day. Based on previous assignments[@R15], we measured exchange for 132 residues, including extensive probes throughout the amyloid core of both the Sc4 and Sc37 conformations.

The H/D exchange experiments revealed that the PNM2 mutation induced specific, localized structural defects in the Sc37 conformation. Specifically, we observed a region of increased exchange in residues proximal to the site of the PNM2 mutation for both early and late exchange time points ([Fig. 4a,b](#F4){ref-type="fig"}). Consistent with this result, we observed a decrease in the thermal stability of PNM2 SupNM Sc37 fibers (T~m~ = 80 °C ± 2) compared to WT SupNM Sc37 fibers (T~m~ = 86 °C ± 2) ([Fig. 3c,d](#F3){ref-type="fig"}). Additionally, when subjected to shearing forces, PNM2 SupNM Sc37 fibers fragmented more than WT SupNM Sc37 fibers ([Fig. 3e](#F3){ref-type="fig"}). These results suggest that the PNM2 mutation in the Sc37 conformation causes a localized structural destabilization with a resulting decrease in fiber stability.

The affects of the PNM2 mutation on Sc37 fibers may have opposing consequences for prion propagation. The localized structural defect would be expected to enhance the rate of prion division *in vivo*, causing an increase in the rate of generation of free fiber ends and subsequently strengthening the prion phenotype[@R15],[@R16]. In contrast, the decrease in fiber growth would be expected to reduce monomer addition onto fibers and weaken the prion phenotype. Therefore, we hypothesize that the modest overall effect of the PNM2 mutation on the \[*PSI*^+^\]^Sc37^ phenotype is the result of compensatory changes.

PNM2 does not affect Sc4 growth, stability or structure {#S5}
-------------------------------------------------------

To determine the mechanism by which the PNM2 mutation interferes with \[*PSI^+^*\]^Sc4^ propagation, we carried out a set of experiments on Sc4 fibers analogous to those done on the Sc37 conformation. When seeded by Sc4, PNM2 SupNM polymerizes into the Sc4 conformation at a rate similar to WT SupNM indicating that the negative effect of the PNM2 mutation on \[*PSI^+^*\]^Sc4^ propagation cannot be explained by a decrease in fiber growth rate ([Fig. 3a,b](#F3){ref-type="fig"}). The Sc4 fiber structure was also unaffected by the PNM2 mutation: H/D exchange experiments showed no appreciable differences between WT SupNM and PNM2 SupNM fibers in the Sc4 conformation ([Fig. 4c,d](#F4){ref-type="fig"}). Both the regions of protection and the extent of protection for all residues was virtually indistinguishable between the two samples for both short and long exchange times, suggesting that the structures were stable as well as very similar. Consistent with the above results, the melting temperatures of WT SupNM and PNM2 SupNM in the Sc4 conformation were comparable (77 °C ± 2 and 77 °C ± 5, respectively) ([Fig. 3c,d](#F3){ref-type="fig"}). Lastly, when subjected to shearing forces, both PNM2 SupNM and WT SupNM fragmented to a similar extent ([Fig. 3e](#F3){ref-type="fig"}).

Taken together, these results argue that PNM2 SupNM is able to polymerize into fibers with growth, structure and stability indistinguishable from that of WT Sc4 fibers, and that the defect in \[*PSI^+^*\]^Sc4^ propagation cannot be explained by the biophysical properties of the fibers.

PNM2 does not affect Sc4-chaperone interactions {#S6}
-----------------------------------------------

Prion propagation is critically dependent on the host chaperone machinery, and in particular on Hsp104p[@R26]. A growing body of evidence indicates that Hsp104p acts in concert with Ssa1p (Hsp70) and Sis1p (Hsp40) to divide prion particles and therefore facilitate prion replication[@R30]--[@R33]. Specifically, Ssa1p and Sis1p bind to prion particles and deliver them to Hsp104p, which is thought to extract prion particles from fibers in an ATP-dependent process that involves translocation of the extracted monomers through its axial pore[@R34]. In addition to its role in propagation, Hsp104p also causes curing of the prion (i.e., conversion from \[*PSI^+^*\] to \[*psi*^−^\]) when expressed at high levels via a mechanism separate from fiber division. Therefore, the overall effect of Hsp104p is a balance between fiber division necessary for propagation at low levels and curing at high levels[@R26]. Since a fiber's differential susceptibility to fragmentation and curing by Hsp104p can directly affect its propagation, we sought to evaluate whether changes in chaperone-prion interactions cause the PNM2 phenotype.

One possible explanation for the interference in \[*PSI^+^*\]^Sc4^ propagation by the PNM2 mutation is that it causes loss of \[*PSI*^+^\] through increased susceptibility to curing by Hsp104p. To explore this possibility, we used a truncated variant of Hsp104p that is missing its N-terminal domain, termed Hsp104ΔNTD[@R35]. When this variant is expressed from the endogenous *HSP104* locus in the genome, it is fully active in \[*PSI*^+^\] propagation and can mediate thermotolerance, but does not cure \[*PSI*^+^\] with overexpression[@R35] ([Supplementary Fig. 1a](#SD1){ref-type="supplementary-material"}). We found that the defect in \[*PSI*^+^\] propagation in PNM2 is observed even in the strain expressing Hsp104ΔNTD establishing that the sectoring seen in PNM2 is not due to curing via the mechanism active with overexpression of Hsp104p ([Fig. 5a](#F5){ref-type="fig"}).

An alternate hypothesis is that the PNM2 mutation causes increased susceptibility to the fiber division activity of Hsp104p leading to fiber resolubilization. To test this, we expressed *HSP104* and *hsp104ΔNTD* from a CEN/ARS plasmid that leads to a 2 to 3-fold increase in expression. At this expression level, wild type Hsp104p destabilized \[*PSI^+^*\] while Hsp104ΔNTD did not ([Fig. 5b](#F5){ref-type="fig"}) indicating that the destabilization must be due to the curing activity of Hsp104p and not over-fragmentation. Importantly, we find that overexpression of Hsp104ΔNTD did not enhance PNM2 sectoring arguing that PNM2 fibers are not overly susceptible to fragmentation and resolubilization by Hsp104p ([Fig. 5b](#F5){ref-type="fig"}, [Supplementary Fig. 1b](#SD1){ref-type="supplementary-material"}). These results are distinct from those of Serio and coworkers (NSMB This Issue), who found that the PNM2 mutation can lead to fiber destabilization and enhanced Hsp104p-mediated fiber dissolution. The differences between the two studies likely results from differences in the prion strain conformations that were examined as Serio et al. observe dominant curing of \[*PSI^+^*\] when WT and PNM2 Sup35p are coexpressed whereas we find that the PNM2 phenotype is recessive in Sc4. Additionally, the fact that the PNM2 mutation destabilizes the fibers in those studies suggest that residue 58 is within the amyloid core of their strain conformation. Indeed we have generated examples of prion strain conformation that, like the Sc4 conformation lead to "strong" prion phenotypes, but nonetheless have amyloid cores that extend across residue 58 (unpublished data).

In an independent assay of Hsp104p activity, we looked at the size distribution of prion fibers by semi-denaturing detergent-agarose gel electrophoresis (SDD-AGE). Previous studies have shown that changes in Hsp104p activity affect aggregate size[@R36] and that Sc37 fibers, which are severed less efficiently by Hsp104p *in vivo*, are larger than those in the Sc4 conformation[@R16]. We examined the relative sizes of Sc37 and Sc4 fibers and found that PNM2 and WT Sc4 fibers have the same size distribution ([Fig. 5c](#F5){ref-type="fig"}). This finding is in agreement with our Hsp104ΔNTD data and indicates that PNM2 and WT Sc4 interact equally with Hsp104p.

Finally, to more directly look at interactions between Hsp104p and Sc4 fibers, we used a system developed to monitor the flux of substrates through the axial pore of Hsp104p ([Fig. 5d](#F5){ref-type="fig"}). Tessarz et al.[@R34] and Tipton et al.[@R33] engineered derivatives of Hsp104p (HAP and 4BAP, respectively) that interact with ClpP, a bacterial protein that forms a proteolytic chamber. When used in conjunction with a catalytically dead mutant of ClpP (ClpP^trap^), substrates of Hsp104p are translocated through HAP and trapped in the ClpP chamber. Thus, following its induction in HAP-expressing yeast, ClpP^trap^ was affinity purified to identify Hsp104p substrates. Given that translocation through Hsp104p is likely to be the terminal event in an interaction between Sup35p and the chaperone machinery, defects in any aspect of this interaction would be expected to yield a difference in the flux of Sup35p through Hsp104p.

Previous studies have shown that Sup35p is delivered to ClpP^trap^ in a HAP-dependent manner, and HAP only translocates Sup35p into ClpP^trap^ in \[*PSI^+^*\] cells[@R33],[@R34]. Moreover, substantially less Sup35p is trapped in the weak \[*PSI^+^*\]^Sc37^ strain than in the strong, and more efficiently divided[@R16], \[*PSI^+^*\]^Sc4^ strain[@R33]. We both confirmed that WT Sup35p was trapped in a \[*PSI^+^*\]-dependent manner ([Fig. 5e](#F5){ref-type="fig"}), and found that the flux of PNM2 through Hsp104 was similar to WT when expressed as either the sole source of Sup35p or co-expressed with WT ([Fig. 5f,g](#F5){ref-type="fig"}). Therefore, in agreement with our Hsp104ΔNTD and SDD-AGE data, the HAP/ClpP^trap^ system shows that PNM2 Sc4 fibers interact normally with the Hsp104p chaperone machinery necessary for propagation.

PNM2 causes a defect in Sc4 propagon partitioning {#S7}
-------------------------------------------------

We investigated whether the PNM2 mutation causes a defect in delivery of \[*PSI^+^*\]^Sc4^ infectious particles (propagons) to daughter cells during cell division using a method developed by Cox, Ness, and Tuite[@R37]. Briefly, corresponding pairs of mother and daughter cells are separated and grown in media containing guanidine, which reversibly inhibits Hsp104p[@R38]--[@R40], such that the number of propagons remain fixed. As the cells divide, a point is reached at which there is no more than one propagon per cell. When Hsp104p function is restored by removal of guanidine, the number of \[*PSI^+^*\] colonies that arise from the mother versus the daughter reports on the relative number of propagons in each mother/daughter pair. Although this assay does not yield a quantitative measure of the absolute number of prion particles, it allows monitoring of relative propagon numbers and loss of \[*PSI^+^*\] by one of the partners.

Using the above assay for \[*PSI^+^*\]^Sc4^ cells expressing WT or PNM2 Sup35p, we found evidence of partitioning dysregulation in PNM2 \[*PSI^+^*\]^Sc4^ cells ([Fig. 6a,b](#F6){ref-type="fig"}). The mild bias in the distribution of propagons toward the mother and positive correlation between the number of propagons in the mother and daughter WT \[*PSI^+^*\]^Sc4^ cells seen previously[@R37],[@R41] was lost in PNM2 \[*PSI^+^*\]^Sc4^ cells. Strikingly, for a subset of pairs, the mother contained a large number of propagons while the daughter did not inherit any. In contrast, we did not observe any pairs in which the daughter had propagons, but the mother did not. The failure of propagons to partition into daughter cells accounts for the rapid appearance of red \[*psi*^−^\] sectors in PNM2 \[*PSI^+^*\]^Sc4^ yeast colonies.

Discussion {#S8}
==========

Our studies point to a critical role for prion conformation in modulating the effects of changes in the sequence of a prion protein on prion propagation. In the case of \[*PSI^+^*\]^Sc37^, the PNM2 mutation affects the structural and physical characteristics of the amyloid fibers in a manner that has compensatory effects on prion propagation resulting in a mild effect on prion propagation *in vivo*. A different picture, however, emerges from studying PNM2 in the context of \[*PSI^+^*\]^Sc4^, where the mutation does not affect the amyloid structure or chaperone-mediated fiber division, but has a striking negative effect on propagation. The effect of PNM2 on \[*PSI^+^*\]^Sc4^ points to a critical role for the least understood step of \[*PSI^+^*\] propagation: the partitioning of prion particles. In PNM2 \[*PSI^+^*\]^Sc4^ yeast, we observed a pronounced defect in the delivery of aggregates to daughter cells. This finding highlights the question of how \[*PSI^+^*\] prion particles are delivered to daughter cells.

Past studies indicate that the observed mother bias in the allocation of \[*PSI^+^*\] particles is roughly consistent with differences in cell volume between the mother and the daughter, suggestive of partitioning by passive diffusion[@R41]. Other studies point to the potential for more active mechanisms in the segregation of protein aggregates, including the active recruitment of cytosolic aggregates to specific loci[@R42],[@R43]. Because the PNM2 mutation lies outside of the amyloid core of the Sc4 conformation, it could disrupt interactions between this region of the prion protein and host factors responsible for prion segregation.

In support of a role for host factors in prion particle partitioning, we carried out an unbiased genetic screen for high copy suppressors of the PNM2 phenotype, in which we identified multiple independent isolates of two genes, *LSB3* and *ART5*, that when overexpressed minimized sectoring in PNM2 \[*PSI^+^*\]^Sc4^ yeast ([Supplementary Fig. 2a,b](#SD1){ref-type="supplementary-material"}, [Supplementary Methods](#SD1){ref-type="supplementary-material"}). Lsb3p interacts with Las17p as well as the Sla1p/End3p/Pan1p complex, both factors involved in the regulation of actin dynamics[@R44]--[@R46]. The actin cytoskeleton has previously been implicated both in transport of general protein aggregates between mother and daughter cells[@R42] as well as in the regulation of prion formation[@R47],[@R48]. Art5p is primarily uncharacterized, but has proposed activity in the regulation of endocytosis[@R49],[@R50]. While a full characterization of the role of these proteins in prion biology is beyond the scope of this study, it will be interesting to determine how prion particles are affected by actin-based transport and if endocytic pathways play a role in prion delivery to daughter cells.

Recent studies have suggested that size selection plays a vital role in prion particle transmission to daughter cells[@R51]. In this "size-based" model, the small prion particles, which are preferentially propagated to daughter cells, might be the species primarily affected by the PNM2 mutation such that these transmission-competent particles are either not delivered to daughter buds or actively retained in the mother cell. These possibilities may be related to the more general mechanism in which the cell specifically recognizes and concentrates misfolded protein aggregates[@R42],[@R43]. Going forward, an understanding of the relationship between the cellular machinery for segregation of general protein aggregates and prion transmission is essential.

Our studies illustrate the importance of delivery of infectious proteins to daughter cells as a critical step in the \[*PSI^+^*\] propagation cycle. In the future, we anticipate that the \[*PSI^+^*\] system will prove useful for studying how cells survey, partition, and sequester protein aggregates. The PNM2 mutation in the Sc4 conformation should provide a critical tool for such studies, as it exhibits a distinct partitioning defect that is not confounded by changes in amyloid structure or chaperone-mediated fiber division.

Materials and Methods {#S9}
=====================

Strains and plasmids {#S10}
--------------------

All strains were converted to \[*PSI^+^*\] by infection with *in vitro* formed Sc4 or Sc37 fibers. See [Supplementary Information Tables 1 and 2](#SD1){ref-type="supplementary-material"} for full list of strains and plasmids.

Fiber preparation {#S11}
-----------------

Fibers were produced as described previously, using bacterially produced pure SupNM proteins carboxy-terminally tagged with 7x-histidine[@R52].

*In vivo* yeast prion propagation characterization {#S12}
--------------------------------------------------

YJW1110 and YJW1111 were transformed with a *LEU2*-marked plasmid expressing WT or PNM2 from the endogenous promoter (pRS315 WT Sup35p or pRS315 PNM2 Sup35p, respectively). The resulting transformants were selected on media lacking uracil and leucine (SD--Ura--Leu), then subsequently passaged on YEPD, then 5-FOA, then 1/4 YEPD. For the swap back experiment, the \[*PSI^+^*\]^Sc4^ yeast background containing the pRS315 PNM2 Sup35p plasmid was transformed with the original pRS316 WT Sup35p plasmid. Resulting transformants were selected on SD--Ura--Leu. After passaging several times on SD--Ura, colonies that required leucine for growth were identified. The \[*PSI^+^*\] phenotype was determined by observing the color on low adenine media (1/4 YEPD). The degree of sectoring, or loss of \[*PSI*^+^\], was determined by growing cultures in YEPD liquid media for 24 hours at 30 °C and plating onto 1/4 YEPD plates at a density of \~400 colonies per plate. The number of \[*PSI^+^*\] and \[*psi*^−^\] colonies were then counted.

*In vitro* analysis of the physical properties of strain conformations {#S13}
----------------------------------------------------------------------

Fiber growth rates[@R15], thermal stabilities[@R8], and susceptibility to shearing[@R16] were all determined as described previously.

H/D exchange NMR {#S14}
----------------

Uniformly ^15^N labeled SupNM was expressed in *E. coli* and purified as previously described^15^. ^15^N-SupNM seeded fibers of each strain were made as described[@R15] and concentrated to 1/25th of their original volume. The fibers were then diluted 1:10 into D~2~O buffer at pH 7.0 to begin the exchange. After the desired time, exchange was quenched by adjusting the pH to 2.5, and fibers were centrifuged at 100,000*g* for 25 min. The pellet was washed once with 5mM DCl in D~2~O, then centrifuged again at 100,000*g* for 20 min. The pellet was frozen, freeze-dried and stored at −80 °C until NMR acquisition. The NMR spectra were acquired as described previously[@R15]. Estimated minimum peak intensity was calculated by averaging the intensity of a set of fully exchanged residues.

*In vivo* analysis of Hsp104p activity using the variant Hsp104ΔNTD {#S15}
-------------------------------------------------------------------

The Hsp104p variant Hsp104ΔNTD, first constructed by Hung and Masison[@R35], has the nucleotides corresponding to the N-terminal 146 residues deleted. *hsp104ΔNTD* was amplified and fused to the NAT cassette by PCR, and inserted into the *HSP104* genomic locus of YJW1110 by homologous recombination, resulting in strain YJW1667. Plasmids pRS399 Hsp104p and pRS399 Hsp104ΔNTD[@R35] were used to mildly (2--3 fold) overexpress Hsp104p or Hsp104ΔNTD. pRS399 is a pRS315 plasmid where the *LEU2* marker has been replaced by a KanR cassette. Plasmids were transformed into YJW1110 and plated on 1/4 YEPD containing the antibiotic G418 for visualization of the \[*PSI^+^*\] phenotype.

Semi-Denaturing Detergent-Agarose Gel Electrophoresis (SDD-AGE) {#S16}
---------------------------------------------------------------

Relative aggregate size was determined by SDD-AGE as previously described[@R53],[@R54]. Sup35p was probed for by western blotting using polyclonal anti-SupNM.

ClpP^trap^ Affinity Purification Experiments {#S17}
--------------------------------------------

The ClpP^trap^ affinity purification experiments were performed as described previously[@R34]. Briefly, YJW1112, YJW1113, YJW1114, or YJW1115 that had been transformed with pRS313 WT Sup35p, pRS313 PNM2 Sup35p, pRS313 WT Sup35HA, or pRS313PNM2 Sup35HA were grown in SD media with 50 μM CuSO~4~ from OD~600~ = 0.1 to 1 and lysed at 4 °C by bead beating in IP buffer (50 mM Tris/Cl pH 8.0, 1 M NaCl, 2 mM EDTA, 0.5% (v/v) Triton X-100, 5 mM β-mercaptoethanol, + Roche Complete Protease Inhibitor Cocktail). The lysate was cleared by centrifugation at 15,000*g* for 15 min, incubated with Streptavidin Sepharose (GE Healthcare) at RT for 1 hr, washed with 40 column volumes of IP buffer, and eluted in IP buffer + 150 mM NaCl and 4 mM biotin. The eluate was subjected to SDS-PAGE and Sup35p was probed for by western blotting using polyclonal anti-SupNM.

Mother/Daughter propagon counting {#S18}
---------------------------------

The propagons in mothers and daughters were counted as described previously[@R37]. Briefly, mothers and daughters of YJW1110 (containing pRS315 WT Sup35p or pRS315 PNM2 Sup35p as the sole source of Sup35p) were separated by micromanipulation onto YEPD plates containing 3mM Guanidine HCl. After growing at 30 °C for about 40 hours, whole colonies were isolated using a cut pipette tip, resuspended in a small volume of H~2~O, and plated onto SD--Ade + 5% (w/v) YEPD. After growing at 30 °C for 10 to 14 days, the number of \[*PSI^+^*\] colonies was counted. For the WT samples, \[*PSI^+^*\] colonies were easily distinguished from \[*psi*^−^\] and Ade revertants by color. The PNM2 samples contained background indistinguishable from true \[*PSI^+^*\] colonies by color. We estimated the average background by repeating the experiment using a \[*psi*^−^\] PNM2 strain created by curing the \[*PSI^+^*\]^Sc4^ PNM2 strain by successive passaging on YEPD containing 3 mM guanidine HCl. The average background of \~25 colonies per sample was subtracted for all counted values.
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![Characterization of *in vivo* prion phenotypes\
**(a)** Expression levels of WT or PNM2 expressed from a plasmid in a \[*PSI^+^*\]^Sc4^ background. Expression levels were quantitated by immunoblotting with a polyclonal anti-SupNM antibody. Values represent the mean ± s.d. for three experiments. **(b)** Representative *in vivo* prion phenotypes of yeast spotted on low adenine media. WT Sup35p was replaced with (left panel), or was co-expressed with (middle panel) either WT or PNM2. **(c)** Enlarged view of the edge of the yeast spot. Presence of red sectors in \[*PSI^+^*\]^Sc4^ PNM2 indicates a loss of \[*PSI^+^*\]. **(d)** Quantification of loss of \[*PSI^+^*\] as determined by counting the number of \[*psi*^−^\] colonies after growing for 24 hours in YEPD. Values represent the mean ± s.d. for three experiments. **(e)** Representative *in vivo* prion phenotypes of yeast spotted on low adenine media. WT Sup35p was replaced with PNM2, which was subsequently replaced with WT through plasmid exchanges.](nihms270224f1){#F1}

![Schematic of the prion propagation cycle that includes (1) fiber growth, (2) chaperone mediated division, and (3) partitioning to daughter cells.](nihms270224f2){#F2}

![Characterization of the physical properties of fibers formed *in vitro*.\
**(a)** A representative experiment monitoring the relative growth rates of WT and PNM2 SupNM. Polymerization of SupNM was performed with 5% (w/w) WT seed of the specified conformation, and the rate of addition of SupNM monomers was monitored by Thioflavin T fluorescence. Data were normalized to initial and final intensities. **(b)** The growth rates of Sc4 and Sc37 PNM2 SupNM normalized to those of WT SupNM polymerized on the relevant seed. Initial time points were fitted to a line and the slope (initial growth rate) was calculated. Values represent the mean ± s.d. for three experiments. **(c,d)** Thermal stability of WT and PNM2 fibers in Sc4 and Sc37 conformations. WT and PNM2 SupNM fibers in the Sc4 or Sc37 conformations were incubated at increasing temperatures, and samples were subjected to SDS-PAGE. Band intensities (susceptibility of aggregates to thermal solubilization) were plotted against temperature and fitted to a sigmoidal function. **(e)** Relative seeding efficacy of WT or PNM2 fibers in the Sc4 or Sc37 conformation before and after stirring for 30 or 60 min. Seeding efficacy was determined by monitoring the initial fiber growth rates of polymerization reactions using stirred samples as seeds. Values represent mean ± s.e.m. for three experiments.](nihms270224f3){#F3}

![H/D exchange of WT and PNM2 SupNM fibers. Intensities for assigned and unambiguous peaks corresponding to residues 1--141 were plotted as the fraction of the non-exchanged intensity after 2 min **(a, c)** and 1 day **(b, d)** of exchange for both WT (blue) and PNM2 (red) fibers in the Sc37 **(a, b)** and Sc4 **(c, d)** conformations. Unassigned and ambiguous residues are not displayed. The gray line represents the estimated minimum peak intensity following complete exchange.](nihms270224f4){#F4}

![PNM2 fibers in the Sc4 conformation interact with the *in vivo* chaperone machinery. **(a)** *HSP104* (top row) and *hsp104ΔNTD* (bottom row) were expressed in \[*PSI*^+^\]^Sc4^ yeast expressing either WT (left) or PNM2 (right) Sup35p and spotted onto low adenine media. **(b)** *HSP104* and *hsp104ΔNTD* were expressed at increased levels along with endogenous Hsp104p in \[*PSI*^+^\]^Sc4^ yeast expressing WT or PNM2 Sup35p. "Vector only" denotes transformation with an empty CEN/ARS plasmid. **(c)** SDD-AGE analysis of prion particle size in duplicate from lysates of \[*PSI*^+^\]^Sc4^ (lanes 1--2 and 5--6), \[*PSI*^+^\]^Sc37^ (lanes 3--4) and PNM2 \[*PSI*^+^\]^Sc4^ (lanes 7--8). *SUP35* is genomic in lanes 1--4 and on a plasmid in lanes 5--8. Yeast express wild type *HSP104* in all lanes. **(d)** Schematic of the *in vivo* HAP/ClpP^trap^ reaction. **(e)** Representative blot of the ClpP^trap^ affinity purification. WT Sup35p and ClpP^trap^ were expressed in backgrounds that were \[*PSI^+^*\]^Sc4^ or \[*psi*^−^\] expressing HAP or Hsp104p. **(f)** Monitoring the translocation of PNM2. HAP and ClpP^trap^ were expressed in \[*PSI^+^*\]^Sc4^ cells that also expressed WT or PNM2 Sup35p. Intensities of Sup35p elution signal from western blot (top panel) were normalized for input signal (bottom panel). **(g)** Monitoring translocation of PNM2 when co-expressed with WT. As in (f), but untagged WT Sup35p was also expressed in cells expressing HA-tagged WT or PNM2 Sup35p. The higher molecular weight band corresponds to HA-tagged Sup35p. Intensities of tagged-Sup35p elution signals were normalized for input signal and for untagged-Sup35p elution signal. For Sup35 intensity, values are expressed as mean ± s.e.m for three experiments.](nihms270224f5){#F5}

![PNM2 in the Sc4 conformation shows a defect in partitioning\
The number of propagons in the daughter was plotted against number of propagons in the mothers for both WT **(a)** and PNM2 **(b)** \[*PSI^+^*\]^Sc4^ backgrounds. Red dots represent mother/daughter pairs in which the mother contained propagons, but the daughter did not.](nihms270224f6){#F6}
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